Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.


Angiotensin-receptor Blocker Therapy—Chronic Kidney Disease and Diabetes


US Cardiology 2006;3(2):32–4

The Role of Oral Vasoactive Agents in the Treatment of Pulmonary Arterial Hypertension


US Cardiology 2006;3(1):39–42

Underutilization of Aspirin in US Ambulatory Care for the Prevention of CVD


US Cardiology 2006;3(1):27–9

Evaluation and Diagnosis of Pulmonary Arterial Hypertension


US Cardiology 2006;3(1):30–2